Insiders who reported open-market trades in the last 12 months at the companies A. Sinclair Dunlop files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Cedric Francois - $980K in APLS purchases and sales in the last 12 months
David O. Watson - $697K in APLS purchases and sales in the last 12 months
A. Sinclair Dunlop is a corporate insider of Apellis Pharmaceuticals, Inc. (APLS). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did A. Sinclair Dunlop last file a Form 4?
The most recent primary Form 4 on record is dated 14 May 2026, one of 5 filings going back to 2025.
Has A. Sinclair Dunlop been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($2.15M) across all tracked filings.
A. Sinclair Dunlop files SEC Form 4 reports at Apellis Pharmaceuticals, Inc. (APLS). 5 SEC Form 4 filings on record going back to 2025, most recently on 14 May 2026. Most recent open-market trade: sold $738K of APLS on 15 October 2025. Lifetime open-market sales: $2.15M.
Recent transactions
13
The latest 13 SEC Form 4 transactions reported by A. Sinclair Dunlop.
InsiderAlpha's records for A. Sinclair Dunlop go back to 2025: 5 primary Form 4 filings, an average of 2.5 per year. 3 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
